Follow
Gina DeNicola
Gina DeNicola
Verified email at moffitt.org
Title
Cited by
Cited by
Year
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
KP Olive, MA Jacobetz, CJ Davidson, A Gopinathan, D McIntyre, ...
Science 324 (5933), 1457-1461, 2009
35242009
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
GM DeNicola, FA Karreth, TJ Humpton, A Gopinathan, C Wei, K Frese, ...
Nature 475 (7354), 106-109, 2011
22742011
In vivo identification of tumor-suppressive PTEN ceRNAs in an oncogenic BRAF-induced mouse model of melanoma
FA Karreth, Y Tay, D Perna, U Ala, SM Tan, AG Rust, G DeNicola, ...
Cell 147 (2), 382-395, 2011
7282011
The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
CE Massie, A Lynch, A Ramos‐Montoya, J Boren, R Stark, L Fazli, ...
The EMBO journal 30 (13), 2719-2733, 2011
6982011
NRF2 regulates serine biosynthesis in non-small cell lung cancer
GM DeNicola, PH Chen, E Mullarky, JA Sudderth, Z Hu, D Wu, H Tang, ...
Nature genetics 47 (12), 1475, 2015
6652015
Connecting copper and cancer: from transition metal signalling to metalloplasia
EJ Ge, AI Bush, A Casini, PA Cobine, JR Cross, GM DeNicola, QP Dou, ...
Nature Reviews Cancer 22 (2), 102-113, 2022
6322022
The complex interplay between antioxidants and ROS in cancer
IS Harris, GM DeNicola
Trends in cell biology 30 (6), 440-451, 2020
4352020
NRF2 promotes tumor maintenance by modulating mRNA translation in pancreatic cancer
IIC Chio, SM Jafarnejad, M Ponz-Sarvise, Y Park, K Rivera, W Palm, ...
Cell 166 (4), 963-976, 2016
3512016
Identification of a small molecule inhibitor of 3-phosphoglycerate dehydrogenase to target serine biosynthesis in cancers
E Mullarky, NC Lucki, R Beheshti Zavareh, JL Anglin, AP Gomes, ...
Proceedings of the National Academy of Sciences 113 (7), 1778-1783, 2016
2932016
The non-essential amino acid cysteine becomes essential for tumor proliferation and survival
JA Combs, GM DeNicola
Cancers 11 (5), 678, 2019
1942019
Dynamic ROS control by TIGAR regulates the initiation and progression of pancreatic cancer
EC Cheung, GM DeNicola, C Nixon, K Blyth, CF Labuschagne, ...
Cancer cell 37 (2), 168-182. e4, 2020
1852020
Depletion of a putatively druggable class of phosphatidylinositol kinases inhibits growth of p53-null tumors
BM Emerling, JB Hurov, G Poulogiannis, KS Tsukazawa, R Choo-Wing, ...
Cell 155 (4), 844-857, 2013
1822013
Non-canonical glutamate-cysteine ligase activity protects against ferroptosis
YP Kang, A Mockabee-Macias, C Jiang, A Falzone, N Prieto-Farigua, ...
Cell metabolism 33 (1), 174-189. e7, 2021
1802021
Cancer’s fuel choice: new flavors for a picky eater
GM DeNicola, LC Cantley
Molecular cell 60 (4), 514-523, 2015
1562015
C-Raf Is Required for the Initiation of Lung Cancer by K-RasG12D
FA Karreth, KK Frese, GM DeNicola, M Baccarini, DA Tuveson
Cancer discovery 1 (2), 128-136, 2011
153*2011
Oncogenic KRAS induces NIX-mediated mitophagy to promote pancreatic cancer
TJ Humpton, B Alagesan, GM DeNicola, D Lu, GN Yordanov, ...
Cancer discovery 9 (9), 1268-1287, 2019
1342019
Deubiquitinases maintain protein homeostasis and survival of cancer cells upon glutathione depletion
IS Harris, JE Endress, JL Coloff, LM Selfors, SK McBrayer, JM Rosenbluth, ...
Cell metabolism 29 (5), 1166-1181. e6, 2019
1272019
Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer
ME Caldwell, GM DeNicola, CP Martins, MA Jacobetz, A Maitra, ...
Oncogene 31 (12), 1599-1608, 2012
1052012
Proteogenomic landscape of squamous cell lung cancer
PA Stewart, EA Welsh, RJC Slebos, B Fang, V Izumi, M Chambers, ...
Nature communications 10 (1), 3578, 2019
972019
Cysteine dioxygenase 1 is a metabolic liability for non-small cell lung cancer
YP Kang, L Torrente, A Falzone, CM Elkins, M Liu, JM Asara, CC Dibble, ...
Elife 8, e45572, 2019
902019
The system can't perform the operation now. Try again later.
Articles 1–20